Arkolith/Insider Trading/MRNS/Form 4

Hulihan Joseph

CHIEF MEDICAL OFFICERMARINUS PHARMACEUTICALS, INC. (MRNS) · full profile →Form 4 · filed Feb 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
2 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2025Disposed to issuer(D)56K$0.55$31K0
Feb 7, 2025Disposed to issuer(D)17K$0.55$9K56K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2025Disposed to issuer(D)100K—$00
Feb 11, 2025Disposed to issuer(D)101K—$00
Feb 11, 2025Disposed to issuer(D)49K—$00
Feb 11, 2025Disposed to issuer(D)98K—$00
Feb 11, 2025Disposed to issuer(D)115K—$00
Feb 11, 2025Disposed to issuer(D)77K—$00
Feb 11, 2025Disposed to issuer(D)115K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-011246) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML